Related Experiment Videos
Omalizumab is effective in cold urticaria-results of a randomized placebo-controlled trial
Martin Metz1, Andrea Schütz1, Karsten Weller1
1Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
The Journal of Allergy and Clinical Immunology
|April 9, 2017
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Global Real-World Validation of First-Day Urticaria Activity Score (UAS1).
The journal of allergy and clinical immunology. In practice·2026
Diagnostic Delay in Patients With Chronic Urticaria: Results From the Chronic Urticaria Registry (CURE).
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Current treatment practices and efficacy in solar urticaria: insights from a patient survey.
Frontiers in immunology·2025
Key Predictors of Adherence to a Mobile Health App for Managing Chronic Spontaneous Urticaria.
Clinical and translational allergy·2025
ABACHAI - Safety and efficacy of abatacept (s.c.) in patients with CTLA4 insufficiency or LRBA deficiency, a phase II clinical trial.
The Journal of allergy and clinical immunology·2026
Age-stratified CD19+ B cell reference values in children and adolescents -a systematic review and meta-analysis.
The Journal of allergy and clinical immunology·2026
Exploiting KREC: Time for newborn screening and beyond-proceedings from the First International KREC Consortium Meeting.
The Journal of allergy and clinical immunology·2026
Reframing the asthma microbiome: Multikingdom, multisite, and multiomic perspectives.
The Journal of allergy and clinical immunology·2026
The Staphylococcus aureus serine protease-like protein B is a potent allergen in a murine asthma model.
The Journal of allergy and clinical immunology·2026
Pumping the brakes: immune checkpoints as regulators of immunity and targets of cancer therapy.
The Journal of allergy and clinical immunology·2026
An Exploratory One Health Investigation of Mycobacterium tuberculosis Complex at the Camel-Human Interface in Abu Dhabi Emirate, United Arab Emirates.
Transboundary and emerging diseases·2026
Type 2-interferon imbalance in allergic barrier disease: An asthma-centered, cross-disease perspective.
Asian Pacific journal of allergy and immunology·2026
Unraveling the "Anxiety-Adherence Paradox": Illness Perception Clusters Predict Non-Adherence in Newly Diagnosed Asthma.
The Journal of asthma : official journal of the Association for the Care of Asthma·2026